It looks to me that Kimberly Clark (UK) are targeting the $3B transdermal patch market using imprint technology in a new development program with imprint supplier – Obducat (Sweden). Kimberly-Clark is ...

DUBLIN--(BUSINESS WIRE)--The "Global Transdermal Patches Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. The global transdermal patches market is ...

MIAMI--(BUSINESS WIRE)--Hisamitsu Pharmaceutical Co., Ltd. (Headquarters: Tosu City, Saga Prefecture, President and Chief Executive Officer (CEO): Hirotaka Nakatomi, hereinafter "Hisamitsu ...

Daytrana (methylphenidate) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). It comes as a transdermal patch that’s usually applied to the skin once per day.

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Aricept ® Patch ...

The European Medicines Agency (EMA) has released two new draft guidelines on, respectively, the quality of oral modified release products and transdermal patches. The two draft guidance documents ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eight years ago, I wrote about a startup trying to deliver cancer ...

Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.

Xulane (norelgestromin/ethinyl estradiol) is a branded-generic prescription drug used to prevent pregnancy. The drug comes as a transdermal patch you apply to your skin once per week for 3 weeks each ...